Seres Therapeutics (MCRB) vs TransCode Therapeutics (RNAZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
TransCode Therapeutics is the larger company by market cap ($29.3 million vs $26.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MCRB | RNAZ |
|---|---|---|
| Share price | $2.59 | $1.73 |
| Market cap | $25.97M | $29.29M |
| 1-day change | -4.96% | -1.70% |
| YTD return | — | -74.23% |
| 1-year return | — | -85.60% |
| 5-year return | — | -100.00% |
| EPS (TTM) | $-2.42 | $-52.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.98 | $15.94 |
| 52-week low | $2.42 | $1.52 |
| Distance from 52-week high | -91.38% | -89.15% |
| Average volume | 72.00K | 50.80K |
| Shares outstanding | 10.04M | 16.93M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
MCRB vs RNAZ FAQ
Which is bigger, Seres Therapeutics or TransCode Therapeutics?
TransCode Therapeutics (RNAZ) is larger, with a market capitalization of $29.29M compared with $25.97M for Seres Therapeutics (MCRB).
Are Seres Therapeutics and TransCode Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.